Article
Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.
Journal of the International Neuropsychological Society : JINS - 1 May 2010
Reinvang Ivar, Lundervold Astri J, Wehling Eike, Rootwelt Helge, Espeseth Thomas
Abstract excerpt
Healthy participants (n = 237) aged 45-79 were tested neuropsychologically with tests of memory, speed, and cognitive control and followed up for 3-5 years (mean, 3.4 years). The sample was genotyped for apolipoprotein E (APOE) and CHolinergic Receptor for Nicotine Alpha 4 (CHRNA4), and genetic effects on cognitive function at initial testing and on cognitive decline was studied. We predicted relatively stronger...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
